Newsfeeds Archive - Page 2 of 2

1 minute read

Analyst Says Selecta Biosciences’ Gout Candidate Can Potentially Raise The Bar On Several Fronts

January 31, 2:15 PM

Canaccord Genuity has increased the price target for Selecta Biosciences Inc (NASDAQ:SELB) from $9 to $10 while maintaining the Buy rating ahead of…

ALPMF

1 minute read

News

A Look Into Healthcare Sector Value Stocks

By Benzinga Insights

November 21, 10:45 AM

Understanding Value Stocks A value stock traditionally has a lower price when compared to stock prices of companies…

BXRX

31 minute read

Earnings

Earnings Scheduled For November 3, 2022

By Benzinga Insights

November 3, 5:42 AM

Companies Reporting Before The Bell • Hyatt Hotels (NYSE:H) is estimated to report quarterly earnings at $0.28 per share on revenue of $1.45 billion.

AAOI

3 minute read

Why Rogers Shares Are Trading Sharply Lower; Here Are 33 Stocks Moving Premarket

By Lisa Levin

November 2, 7:58 AM

Gainers Avinger, Inc. (NASDAQ: AVGR) rose 32% to $1.36 in pre-market trading. Avinger is expected to release its financial results for the third quarter on Wednesday, November 9, 2022.

ABNB

1 minute read

Match Group, Super Micro Computer And Some Other Big Stocks Moving Higher In Today’s Pre-Market Session

By Lisa Levin

November 2, 6:08 AM

U.S. stock futures traded slightly higher this morning. Here are some big stocks recording gains in today’s pre-market trading session.

ARCT

2 minute read

Earnings

Selecta Biosciences’s Return On Capital Employed Overview

By Benzinga Insights

August 22, 9:54 AM

Pulled from Benzinga Pro data, Selecta Biosciences (NASDAQ:SELB) showed a loss in earnings since Q1, totaling $8.60 million. Sales, on the other hand, increased by 15.51% to $39.27 million during Q2.

SELB